Investor Alert: Deadline in SCYNEXIS, Inc. Class Action Lawsuit Approaches

Impending Deadline for SCYNEXIS Investors

LOS ANGELES, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The law firm of Glancy Prongay & Murray LLP ("GPM") issues a reminder to investors concerning the fast-approaching January 8, 2024 deadline. Investors who have purchased or otherwise acquired shares of SCYNEXIS, Inc. (SCYX) are urged to contact the firm regarding the class action lawsuit before the lead plaintiff deadline. The lawsuit has been filed on behalf of a class consisting of investors who suffered financial losses due to alleged corporate misconduct.

About SCYNEXIS, Inc.

Headquartered in Jersey City, New Jersey, SCYNEXIS, Inc. (SCYX) is a biotechnology firm specializing in the development of treatments targeting yeast infections. Offering innovative solutions in the healthcare sector, SCYNEXIS aims to improve patient outcomes in the United States and beyond.

Details of the Class Action Lawsuit

The class action lawsuit alleges that SCYNEXIS, Inc. and certain of its executives violated federal securities laws. By failing to disclose material information, it is claimed that the company misled investors, causing them to incur losses once the true details entered the market. Investors who acquired SCYNEXIS shares during the class period and suffered damages may be eligible to participate in the lawsuit and are encouraged to move promptly given the imminent lead plaintiff deadline.

Legal Representation for Affected Investors

GPM is a prominent shareholder rights law firm with a track record of championing investor rights. They offer counsel and advice to investors who have been adversely affected by corporate wrongdoing. Affected SCYX shareholders are prompted to contact GPM to learn more about their legal rights and options as the deadline nears.

What Investors Should Do

If you have purchased SCYNEXIS, Inc. SCYX securities within the class period and wish to serve as a lead plaintiff, you must move the Court no later than January 8, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Potential lead plaintiffs are under no obligation to participate and can retain their own attorney to join the class action. For those who have not yet discovered losses or those uncertain about their eligibility, swift action is advised to ensure compliance with the statutory deadline.

deadline, lawsuit, investors